Intrinsiqs

Is AbbVie Inc. overvalued?

AbbVie Inc. (ABBV) — key valuation metrics and fundamentals.

No verdict
Price
$251.52
Fair value
—
Current P/E
—
Normal P/E
20.9
Market cap
$444.38B
Dividend yield
2.9%
Return on equity
-129.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ABBV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.AMGN Amgen Inc.TMO Thermo Fisher Scientific Inc.